Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07181447 · ClinicalTrials.gov registry record
NIRS for the Diagnosis of Myofascial Pelvic Pain
A clinical trial of Myofascial Pelvic Pain, sponsored by University of California, Los Angeles.
- Recruiting
- Registry status
- 110
- Enrollment target
- 1
- Study location
NCT07181447: Recruiting study of Myofascial Pelvic Pain, sponsored by University of California, Los Angeles.
NCT07181447 is a study of Myofascial Pelvic Pain that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 110 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07181447, a study of Myofascial Pelvic Pain, is actively recruiting participants, sponsored by University of California, Los Angeles.
- RECRUITING
- Registry status
- 110 participants
- Enrollment target
- 1
- Study location
Study Summary
Myofascial Pelvic Pain (MPP) is an often-misdiagnosed condition affecting up to 26% of women during their lives and imposing enormous costs on national health care systems. It frequently involves comorbidities such as bladder, bowel, and sexual dysfunction. There are no quantitative measures that adequately guide the physician and accurate diagnosis typically requires an internal examination by a tertiary specialist. This study will develop and test an instrument to establish a normal range for near infrared spectroscopy (NIRS) optical changes associate with pelvic floor exercise in adult women based on the test-to test (intra-day) reliability of oxygen kinetics related to contraction of the pelvic floor muscle. We will establish the relationship between the quantitative NIRS data, the condition of Myofascial pelvic musculature and the symptomatology of MPP and related comorbidities. We will also evaluate prospectively the effectiveness of these data in predicting effective treatment modalities. Finally, we will optimize a training regime for non-specialists to allow this technique to be used in a variety of settings. The development of this device and validation of its relevance to diagnosis and treatment of MPP will provide effective care sooner and at a lower cost than current procedures. It will also reduce inequities in the availability of care to underserved populations by providing an inexpensive, reliable and easily available method for a variety of providers to address MPP.
Primary Outcome
Accurate Diagnosis of Myofascial Pelvic Pain
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Pelvic Floor Muscle Assessment by Near-Infrared Spectroscopy
Study Locations (1)
California
- UCLA Center for Women's Pelvic Health - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2025-01-23 |
| Est. Completion | 2026-09-01 |
What NCT07181447 shows while recruiting
NCT07181447 is an observational study that tracks outcomes without assigning an intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Myofascial Pelvic Pain appearing as the primary indexed condition, and to 1 intervention - of which Pelvic Floor Muscle Assessment by Near-Infrared Spectroscopy is the first listed.
NCT07181447 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07181447 about?
NCT07181447 is a clinical study titled "NIRS for the Diagnosis of Myofascial Pelvic Pain". Myofascial Pelvic Pain (MPP) is an often-misdiagnosed condition affecting up to 26% of women during their lives and imposing enormous costs on national health care systems. It frequently involves comorbidities such as bladder, bowel, and sexual dysfunction. There are no quantitative measures that ad...
What is the current status of trial NCT07181447?
This trial is currently recruiting. The enrollment target is 110 participants. The study started on 2025-01-23. Estimated completion is 2026-09-01.
What conditions does trial NCT07181447 study?
This clinical trial studies the following conditions: Myofascial Pelvic Pain.
What interventions are being tested in trial NCT07181447?
The interventions under investigation include: Pelvic Floor Muscle Assessment by Near-Infrared Spectroscopy (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07181447?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07181447 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myofascial Pelvic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI